>>18846429Puberty blockers, primarily GnRH analogues, are medically established for treating precocious puberty and are used off-label for gender dysphoria to pause physical development. While generally considered safe for precocious puberty, their use for gender dysphoria is currently controversial, with NHS England banning routine prescription in 2024 due to insufficient evidence regarding long-term safety and effectiveness.
Potential health impacts and side effects associated with puberty blockers include:
Bone Health: Reduced bone density and potential long-term effects on bone strength, which may require monitoring and supplementation.
Fertility: Concerns exist regarding potential long-term impacts on fertility, particularly if followed by cross-sex hormone therapy; some studies suggest possible permanent effects on sperm cell development in boys.
Mental Health: Effects are mixed; while some studies link use to reduced suicidal ideation and improved wellbeing, others report mood swings, irritability, depression, or anxiety.
Other Physical Effects: Common side effects include headaches, hot flashes, fatigue, injection site reactions, and potential impacts on cognitive development or brain structure.
The FDA has not approved these drugs for gender dysphoria, though they are approved for precocious puberty and other conditions like prostate cancer. Medical consensus varies, with some experts viewing the treatment as lifesaving for reducing distress, while others, including reviews in the UK, Sweden, and Finland, highlight significant uncertainties and risks, recommending psychotherapy as a first-line alternative.